Clinical Trials in Spain — Country Dashboard | 4,847 EU Studies

Filter these 4,847 trials by condition, phase, sponsor and more.

Open in Search →

4,847 Registered trials

1,866 Recruiting

2,540 Completed trials

1,158 Sponsors active

827 Research sites

Phase III

Phase II

Phase III: 1858 Phase II/III: 195 Phase II: 1245 Phase I/II: 318 Phase III/IV: 55 Phase IV: 271 Phase I: 331 Phase I (Other): 273 Phase I (FiH): 244 Other: 54 Other: 3

Oversight events in trials active here:

133 serious breaches 1018 temporary halts 82 urgent safety measures 101 unexpected events 158 corrective measures across 562 trials

View oversight register →

Top conditions

Non-small cell lung cancer 189 Non-small cell lung cancer metastatic 61 Ovarian cancer 55 Colorectal cancer 48 Breast cancer 48 Systemic lupus erythematosus 41 Endometrial cancer 35 Squamous cell carcinoma of head and neck 35 Myelodysplastic syndrome 32 Diffuse large B-cell lymphoma 30 Triple negative breast cancer 30 Prostate cancer metastatic 29

Top sponsors

AstraZeneca AB 203 Merck Sharp & Dohme LLC 200 Novartis Pharma AG 182 F. Hoffmann-La Roche AG 165 Janssen - Cilag International 145 AbbVie Deutschland GmbH & Co. KG 113 Pfizer Inc. 98 Glaxosmithkline Research & Development Limited 78 Bristol-Myers Squibb Services Unlimited Company 77 Sanofi-Aventis Recherche & Developpement 74 Boehringer Ingelheim International GmbH 72 Amgen Inc. 71

Cities with most trials

All 231 cities →

All trials — page 28

4,847 total

A study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis Recruiting

2024-511458-32-00 Phase III Ulcerative colitis Alfasigma S.p.A.
An Extension Study to Evaluate Safety, Efficacy, and Durability of Response to ESK-001 for Moderate to Severe Plaque Psoriasis (ONWARD3) Recruiting

2024-511166-36-00 Phase III Moderate to Severe Plaque Psoriasis Alumis Inc.
Efficacy and safety trial of intraperitoneal furosemide in patients on peritoneal dialysis Recruiting

2024-519356-87-00 Phase IV Dialysis Heart failure Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comuni…
Long-term safety and efficacy study of riliprubart in participants with CIDP Recruiting

2024-517032-22-00 Phase III Immune system diseases. Sanofi-Aventis Recherche & Developpement
A Study to assess safety and effectiveness of Emicizumab in Patients with Type 3 Von Willebrand Disease Recruiting

2024-515622-80-00 Phase III Type 3 Von Willebrand Disease F. Hoffmann-La Roche AG
Belimumab CTD-ILD - Long Term Extension/Follow up to pivotal studies BLISSc-ILD and BEconneCTD-ILD Recruiting

2023-509370-39-00 Phase III connective tissue diseases Glaxosmithkline Research & Development Limited
Phase 1b/2 Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Pancreatic Cancer (Substudy PDAC) Recruiting

2024-517819-74-00 Phase I/II Pancreatic Ductal Adenocarcinoma Merck Healthcare KGaA
A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants… Recruiting

2024-514239-21-00 Phase I (Other) Spinal Muscular Atrophy Biogen Idec Research Limited
Long-term Follow-up study for relapsed/refractory (R/R) T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LL) patients previously treated … Recruiting

2024-516617-20-00 Phase III T-cell acute lymphoblastic Lymphoma Onechain Immunotherapeutics S.L.
First trial in humans testing the safety and efficacy of IMGN151 in women with recurrent gynaecological cancers Recruiting

2023-506842-22-00 Phase I (FiH) Recurrent endometrial cancer, recurrent epithelial ovarian, … AbbVie Deutschland GmbH & Co. KG
Long-term Safety and Tolerability of TAK-881 in Subjects with Primary Immunodeficiency Diseases (PIDD) Recruiting

2023-505946-24-00 Phase III Primary Immunodeficiency Diseases Baxalta Innovations GmbH; Takeda Development Center Americas Inc.
Impact of Albumin on Renal function in critically ill patients with Septic Shock and a high risk of Acute Kidney Injury. A Randomized Contro… Recruiting

2024-518475-58-00 Phase IV Septic shock, acute kidney injury Fundacio Parc Tauli
A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Pso… Recruiting

2024-515706-77-00 Phase III Moderate to Severe Plaque Psoriasis Janssen Cilag International
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients with FLT3-ITD Negative AML Recruiting

2023-507936-20-00 Phase III Acute myeloid leukemia Daiichi Sankyo Inc.
A Study to see How Well and How Safely Different Treatments Work in a Group of Patients with Non-Small Cell Lung Cancer, Chosen Based on the… Recruiting

2024-511239-91-00 Phase II Resectable Stage I-III Non-Small Cell Lung Cancer (NSCLC) F. Hoffmann-La Roche AG
Toward personalized medicine to guide drug withdrawal in children with juvenile idiopathic arthritis in clinical remission: a randomized cli… Recruiting

2024-514732-24-00 Phase IV Juvenile idiopathic arthritis IRCCS Istituto Giannina Gaslini
A study to evaluate the safety, tolerability, and pharmacokinetics of VABOMERE (meropenem-vaborbactam) in children with complicated urinary … Recruiting

2024-516360-29-00 Phase II Complicated Urinary Tract Infection (cUTI), Acute Pyeloneph… Rempex Pharmaceuticals Inc.
A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab a… Recruiting

2023-505172-29-00 Phase II Resectable Non-small Cell Lung Cancer Regeneron Pharmaceuticals Inc.
A Phase 2 Study of AMG 193 in Subjects With MTAP-deleted Advanced NSCLC Recruiting

2024-514459-14-00 Phase II Non-Small Cell Lung Cancer Amgen Inc.
An Open-Label, Phase 1 Study of the CTPS1 Inhibitor STP938 in Adult Subjects with Advanced Solid Tumors, with a Safety Expansion in Advance… Recruiting

2024-512375-12-00 Phase I (Other) Solid tumors and ovarian cancer Step Pharma
Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With AS (Aspire) Recruiting

2024-512600-19-00 Phase III Angelman Syndrome Ultragenyx Pharmaceutical Inc.
A clinical study of sacituzumab tirumotecan in people with ovarian cancer (MK-2870-022) Recruiting

2023-508015-23-00 Phase III Ovarian cancer recurrent Merck Sharp & Dohme LLC
A dose ranging study to investigate efficacy and safety of subcutaneous TOUR006 compared with placebo in participants 18 to 80 years of age … Recruiting

2024-514801-69-00 Phase II Thyroid Eye Disease Tourmaline Bio Inc.
A Multicenter, Randomized, Double-Blind, Active Comparator-Controlled, Adaptive Phase 2/3 Study to Evaluate the Safety and Efficacy of EIK10… Recruiting

2024-512659-19-00 Phase II/III Advanced Melanoma Eikon Therapeutics Inc.

Showing 649–672 of 4,847 trials

← All countries